Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Recent News

06/06/17Global Blood Therapeutics Announces Participation at the Goldman Sachs 38th Annual Global Healthcare Conference
05/18/17Global Blood Therapeutics Announces Upcoming Presentation of GBT440 Data in Adolescents with Sickle Cell Disease at European Hematology Association’s 22nd Congress
05/01/17Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results
03/29/17Global Blood Therapeutics to Present at the 16th Annual Needham Healthcare Conference

More »

Media Resources

Media Contact

Julie Normart